Scottsdale, Arizona 7/23/2008 2:24:36 AM
News / Finance

QualityStocks News – GeoPharma, Inc. (GORX) Adds New Distribution Channels for Mucotrol™ in India, Nepal, Bangladesh, Sri Lanka and South Korea

At http://www.qualitystocks.net/ you can sign up for Quality Stock's Daily Newsletter to find out what Small-Cap and Micro-Cap online Investment Newsletters are interested in, plus hear about the latest news from our clients as well as other publicly traded companies.

 

We would like to highlight GeoPharma, Inc. (NASDAQ: GORX). The company manufactures, packages and distributes private label dietary supplements, generic drugs, and health and beauty products for companies worldwide under six of its companies: Innovative Health Products, Inc., Libi Labs, Belcher Pharmaceuticals, Inc., American Antibiotics, LLC, Breakthrough Engineered Nutrition, Inc., EZ-Med Company and Dynamic Health Products, Inc. Innovative Health Products, Inc. and Libi Labs specialize in the development and manufacture of a range of nutritional supplements and cosmeceuticals.

 

In the company’s news yesterday,

 

GeoPharma, Inc. announced the expansion of the company’s distribution agreement with Cura Pharmaceutical Co., a New Jersey-based pharmaceutical marketing company that focuses on select niche markets through the offering of specialty products and services. Under the new aspects of the agreement, two new regional partners will be allowed to distribute Mucotrol™, an FDA-approved medical device, in India, Nepal, Bangladesh, Sri Lanka and South Korea.

 

Mucotrol™ is a concentrated oral gel wafer designed as a pain management method for patients suffering from oral mucositis, which is a formation of mouth lesions that commonly present themselves in a patient’s mouth after undergoing chemotherapy treatments for cancer. By forming a soothing coating on the inside of the patient’s mouth, Mucotrol™ dramatically reduces the sensitivity of mouth lesions, improves the general comfort of the patient and makes activities such as eating much more tolerable.

 

GeoPharma’s expansion of the Cura agreement to include additional worldwide partners is another example of the company’s continued global expansion plan, which includes leveraging its research and manufacturing expertise to develop medical devices and high-margin generic drug products for niche markets with high barriers to entry. The company’s senior management team is pleased that the Mucotrol™ product is generating higher demand and growing its customer base.

 

About QualityStocks

 

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 500,000+ subscribers that receive The Daily Stock Newsletters.

 

To sign up for “The QualityStocks Daily Newsletter” please visit http://www.qualitystocks.net/

 

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net 

 

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.